Scholar Rock: FDA Grants Fast Track And Orphan Drug Designations To Apitegromab

Reports

2

Domains carrying it

2

First reported

2 September 2026

Latest report

3 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 2 September 2026Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral ...biospace.com
2. 3 September 2026Scholar Rock: FDA Grants Fast Track And Orphan Drug Designations To Apitegromabrttnews.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• Phanes Therapeutics Receives FDA Fast Track Designation for Spevatamig in Advanced ...2 reports · 2 domains · 17 August 2026
• FDA sNDA Submission Is Planned for Selinexor Plus Ruxolitinib in Myelofibrosis2 reports · 2 domains · 1 August 2026
• Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of ...2 reports · 2 domains · 31 August 2026
• How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Expanded UK Approval ...2 reports · 1 domains · 22 August 2026
• Regenxbio Hits Regulatory Roadblock After FDA Puts RGX-121 on Hold6 reports · 6 domains · 24 August 2026
• How Investors Are Reacting To Replimune Group (REPL) FDA Accelerated Approval For ...4 reports · 4 domains · 10 August 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Scholar Rock: FDA Grants Fast Track And Orphan Drug Designations To Apitegromabrttnews.com · 3 September 2026
• Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral ...biospace.com · 2 September 2026